Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits

Medical Hypotheses
Mark F McCarty

Abstract

Soy isoflavones, the focus of much research and controversy, are often referred to as "weak estrogens". In fact, genistein is a relatively potent agonist for the recently characterized beta isoform of the estrogen receptor (ERbeta). The low nanomolar serum concentrations of unconjugated free genistein achieved with high-nutritional intakes of soy isoflavones are near the binding affinity of genistein for this receptor, but are about an order of magnitude lower than genistein's affinity for the "classical" alpha isoform of the estrogen receptor (ERalpha). Moreover, these concentrations are far too low to inhibit tyrosine kinases or topoisomerase II, in vitro activities of genistein often cited as potential mediators of its physiological effects. The thesis that these physiological effects are in fact mediated by ERbeta activation provides a satisfying rationale for genistein's clinical activities. Hepatocytes do not express ERbeta; this explains why soy isoflavones, unlike oral estrogen, neither modify serum lipids nor provoke the prothrombotic effects associated with increased risk for thromboembolic disorders. The lack of uterotrophic activity of soy isoflavones reflects the fact that ERalpha is the exclusive mediator of estro...Continue Reading

References

Apr 15, 1975·International Journal of Cancer. Journal International Du Cancer·B Armstrong, R Doll
Jan 25, 1992·BMJ : British Medical Journal·D FouqueP Y Zech
Aug 16, 1989·Journal of the National Cancer Institute·D A SchulsingerT C Campbell
Oct 1, 1989·The Tohoku Journal of Experimental Medicine·H NakamuraA Shibata
Apr 1, 1987·European Journal of Clinical Investigation·A J Williams, J Walls
Nov 1, 1983·Kidney International·S KlahrM L Purkerson
Aug 3, 1995·The New England Journal of Medicine·J W AndersonM E Cook-Newell
Sep 1, 1995·The Journal of Nutrition·X XuS Hendrich
Apr 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S R Silbiger, J Neugarten
Feb 1, 1995·Japanese Journal of Cancer Research : Gann·K HiroseS Tokudome
Jun 1, 1995·British Journal of Cancer·J M YuanM C Yu
Nov 13, 1993·Lancet·H AdlercreutzS Watanabe
May 1, 1994·The American Journal of Clinical Nutrition·T C Campbell, C Junshi
Jul 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G D'Amico, M G Gentile
Jan 1, 1993·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·H AdlercreutzT Hase
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·G G KuiperJ A Gustafsson
Nov 1, 1996·The Journal of Clinical Investigation·T YasudaR C Harris
Dec 1, 1996·Steroids·P J ShughrueI Merchenthaler
Jan 1, 1997·The American Journal of Clinical Nutrition·C R SirtoriP A Murphy
Jun 1, 1997·Journal of the American College of Cardiology·J A McCrohonD S Celermajer
Jan 1, 1997·The Journal of Steroid Biochemistry and Molecular Biology·S KurebayashiT Kishimoto

❮ Previous
Next ❯

Citations

Jun 25, 2008·The British Journal of Nutrition·Claudia SteinerClaudine Manach
Oct 10, 2008·Planta medica·Tawakalitu OseniV Craig Jordan
Aug 7, 2012·Nutrition and Cancer·Sarah J LowryAmy Trentham-Dietz
Nov 27, 2007·SAR and QSAR in Environmental Research·L B SalumA D Andricopulo
Dec 5, 2008·Journal of Medicinal Food·Hea Jin ParkClifton A Baile
Jun 15, 2011·Journal of Medicinal Food·Ching-Yi LaiClifton A Baile
May 12, 2010·Omics : a Journal of Integrative Biology·Samir SatihDominique J Bernard-Gallon
Mar 20, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Lina XingWeidong Hao
Oct 1, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Barbara J FuhrmanRegina G Ziegler
Apr 17, 2008·Environmental Health Perspectives·Sarah M MenseHari K Bhat
Jan 1, 2010·Nutrients·Gertraud MaskarinecJeffrey A Tice
Jul 20, 2013·Nutrition Reviews·Ganji Purnachandra NagarajuBassel F El-Rayes
Feb 15, 2013·Planta medica·Atieh HajirahimkhanJudy L Bolton
Apr 29, 2008·Current Opinion in Endocrinology, Diabetes, and Obesity·Jamey A Sarvis, Ian M Thompson
Jul 1, 2014·Climacteric : the Journal of the International Menopause Society·F-P Chen, M-H Chien
Jan 27, 2009·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Ramiro DipHanspeter Naegeli
Jan 8, 2009·Biochemical and Biophysical Research Communications·Maud PrivatYves-Jean Bignon
Oct 29, 2008·The Journal of Steroid Biochemistry and Molecular Biology·A M SotocaA J Murk
Jun 17, 2008·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Marianne ImhofMartin Imhof
Oct 20, 2006·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Hsin-Jung Wu, Wen-Hsiung Chan
Apr 1, 2016·British Journal of Cancer·Carlos Martínez-PérezSimon P Langdon
Sep 15, 2010·Molecular Aspects of Medicine·Richard C M Siow, Giovanni E Mann
Mar 10, 2015·Nature Biotechnology·Hyun Uk KimSang Yup Lee
Jun 24, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Alessandra BittoFrancesco Squadrito
Nov 26, 2015·Case Reports in Obstetrics and Gynecology·Supanimit TeekachunhateanSurapan Khunamornpong
Oct 6, 2010·Experimental Biology and Medicine·Malcolm R OgbornHarold M Aukema
Nov 30, 2006·Neoplasia : an International Journal for Oncology Research·Paul MakShuk-Mei Ho
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Ronald Tamler, Jeffrey I Mechanick
Jul 11, 2006·Medical Hypotheses·Mark F McCarty
Jul 28, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·H MariniF Squadrito
Nov 30, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Erin B Larson, Marilyn E Carroll
Jun 26, 2018·The Journal of Veterinary Medical Science·Xiao-Xing ChiDong-Jie Zhang
Jul 24, 2007·The Journal of Urology·Ian M Thompson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis